{"name": "Intarcia Therapeutics",
 "permalink": "intarcia-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/intarcia-therapeutics",
 "homepage_url": "http://www.intarcia.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1997,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "busdev@intarcia.com",
 "phone_number": "510-782-7800",
 "description": "",
 "created_at": "Fri Oct 09 10:07:21 UTC 2009",
 "updated_at": "Sun Jun 09 12:40:42 UTC 2013",
 "overview": "\u003Cp\u003EIntarcia Therapeutics, Inc. is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. The company\u00e2\u20ac\u2122s products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. The company was formerly known as BioMedicines, Inc. and changed its name to Intarcia Therapeutics, Inc. in September 2004. Intarcia Therapeutics was founded in 1997 and is based in Hayward, California with an additional office in Mountain View, California.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       85],
      "assets/images/resized/0006/2213/62213v1-max-150x150.png"],
     [[157,
       89],
      "assets/images/resized/0006/2213/62213v1-max-250x250.png"],
     [[157,
       89],
      "assets/images/resized/0006/2213/62213v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman, President \u0026 CEO",
    "person":
     {"first_name": "Kurt",
      "last_name": "Graves",
      "permalink": "kurt-graves",
      "image": null}},
   {"is_past": false,
    "title": "Chief Business Officer and Head of Corporate Development",
    "person":
     {"first_name": "Owen",
      "last_name": "Hughes, Jr",
      "permalink": "owen-hughes-jr",
      "image": null}},
   {"is_past": false,
    "title": "Chief Medical Officer",
    "person":
     {"first_name": "Michelle",
      "last_name": "Baron",
      "permalink": "michelle-baron",
      "image": null}},
   {"is_past": false,
    "title": "CFO \u0026 Vice President, Finance and Operations",
    "person":
     {"first_name": "James",
      "last_name": "M. Ahlers",
      "permalink": "james-m-ahlers",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, General Counsel, Corporate Secretary",
    "person":
     {"first_name": "Barbara",
      "last_name": "McClung",
      "permalink": "barbara-mcclung",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Development and Manufacturing",
    "person":
     {"first_name": "Thomas",
      "last_name": "Alessi",
      "permalink": "thomas-alessi",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Commercial Operations",
    "person":
     {"first_name": "David",
      "last_name": "Franklin",
      "permalink": "david-franklin",
      "image": null}},
   {"is_past": false,
    "title": "Executive Director, DUROS\u00ae Manufacturing",
    "person":
     {"first_name": "Dick",
      "last_name": "Ford",
      "permalink": "dick-ford",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "James",
      "last_name": "Niedel",
      "permalink": "james-niedel",
      "image": null}},
   {"is_past": false,
    "title": "Executive Director, Product Development",
    "person":
     {"first_name": "Janice",
      "last_name": "Dahms",
      "permalink": "janice-dahms",
      "image": null}},
   {"is_past": false,
    "title": "Executive Director, Regulatory Compliance and Quality Assurance",
    "person":
     {"first_name": "Robert",
      "last_name": "Lemmon",
      "permalink": "robert-lemmon",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "Glen",
      "last_name": "Sato",
      "permalink": "glen-sato",
      "image": null}},
   {"is_past": true,
    "title": "CEO",
    "person":
     {"first_name": "Karling",
      "last_name": "Alice Leung",
      "permalink": "karling-alice-leung",
      "image": null}},
   {"is_past": true,
    "title": "Executive Director",
    "person":
     {"first_name": "Thomas",
      "last_name": "Alessi",
      "permalink": "thomas-alessi",
      "image": null}},
   {"is_past": true,
    "title": "Board of Directors",
    "person":
     {"first_name": "Irwin",
      "last_name": "Scher",
      "permalink": "irwin-scher",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$215M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://deals.venturebeat.com/2007/03/20/intarcia-restarts-with-50m-for-hepatitis-diabetes-treatments/",
    "source_description": "Intarcia restarts with $50M for hepatitis, diabetes treatments",
    "raised_amount": null,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 3,
    "funded_day": 20,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quilvest Ventures",
         "permalink": "quilvest-ventures",
         "image":
          {"available_sizes":
            [[[150,
               67],
              "assets/images/resized/0025/7399/257399v1-max-150x150.png"],
             [[245,
               110],
              "assets/images/resized/0025/7399/257399v1-max-250x250.png"],
             [[245,
               110],
              "assets/images/resized/0025/7399/257399v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Enterprise Associates",
         "permalink": "new-enterprise-associates",
         "image":
          {"available_sizes":
            [[[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-150x150.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-250x250.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Omega Funds",
         "permalink": "omega-funds",
         "image":
          {"available_sizes":
            [[[150,
               29],
              "assets/images/resized/0005/9079/59079v1-max-150x150.png"],
             [[250,
               49],
              "assets/images/resized/0005/9079/59079v1-max-250x250.png"],
             [[450,
               88],
              "assets/images/resized/0005/9079/59079v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://deals.venturebeat.com/2010/09/08/intarcia-therapeutics-raises-5m-to-treat-long-term-conditions/",
    "source_description": "Intarcia Therapeutics raises $5M to treat long-term conditions",
    "raised_amount": 5000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 9,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Enterprise Associates",
         "permalink": "new-enterprise-associates",
         "image":
          {"available_sizes":
            [[[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-150x150.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-250x250.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020121115e8bfszh3h\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020121115e8bfszh3h%26from%3dalert%26pid%3d32",
    "source_description": " Intarcia Amasses $210M in Equity, Debt Financing for Type 2 Diabetes Therapy ",
    "raised_amount": 210000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 11,
    "funded_day": 16,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "24650 Industrial Boulevard",
    "address2": "",
    "zip_code": "94545",
    "city": "Hayward",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Intarcia Therapeutics Names Kurt Graves To New Executive Chairman Post.",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 17,
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020100916e69h000jh\u0026r=Rss\u0026s=DJFVW",
    "source_text": "",
    "source_description": "Intarcia Therapeutics Names Kurt Graves To New Executive Chairman Post",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Intarcia Therapeutics",
      "permalink": "intarcia-therapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}